Compare GRDX & MIND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GRDX | MIND |
|---|---|---|
| Founded | N/A | 1987 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.2M | 29.7M |
| IPO Year | 2016 | 1997 |
| Metric | GRDX | MIND |
|---|---|---|
| Price | $3.22 | $2.42 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 147.2K | 64.0K |
| Earning Date | 11-16-2026 | 12-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 21.95 | ★ 29.77 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $42,675,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $73.65 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.87 | $2.53 |
| 52 Week High | $6.93 | $11.39 |
| Indicator | GRDX | MIND |
|---|---|---|
| Relative Strength Index (RSI) | 36.24 | 18.86 |
| Support Level | $3.23 | N/A |
| Resistance Level | $4.19 | $4.78 |
| Average True Range (ATR) | 0.79 | 0.25 |
| MACD | -0.26 | -0.08 |
| Stochastic Oscillator | 26.36 | 1.24 |
GridAI Technologies Corp, formerly known as Entero Therapeutics Inc, is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The company's programs address unmet needs in GI health and include: latiglutenase, a Phase 3-ready, potentially first-in-class, targeted, oral biotherapeutic for celiac disease; capeserod, a selective 5-HT4 receptor partial agonist for indications including gastroparesis; and adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis and chronic pancreatitis patients with exocrine pancreatic insufficiency.
MIND Technology Inc provides technology and solutions for exploration, survey, and defense applications in oceanographic, hydrographic, defense, seismic, and security industries. The company operates in single segment namely, Seamap which provides services and products, including engineering, repairs and software licensing, utilized in marine exploration, marine survey and maritime security for marine survey companies, seismic survey contractors, research institutes, non-military government organizations and operators of port facilities and other offshore installations. The company generates more revenue from Seamap Marine Products. The company's geographical segments include the United States; China, Norway; Turkey; Singapore; and Canada & Other.